Research
Researchers show that a drug for diabetes improves the prognosis of patients undergoing transcatheter aortic valve implantation (TAVI)
Conducted in 39 hospitals in Spain with the scientific coordination of the CNIC and in partnership with Hospital Clínic-IDIBAPS, the DapaTAVI study i1